Olfr486, identified as a G protein-coupled receptor (GPCR), is intricately involved in the complex network of olfactory transduction pathways. As a chemosensory receptor located on the cell membrane of olfactory sensory neurons, Olfr486 plays a crucial role in detecting specific odorants, initiating signaling cascades that ultimately contribute to the olfactory perception of an organism. The receptor's selectivity in recognizing distinct chemical stimuli underscores its significance in shaping the olfactory landscape and influencing an organism's response to its surroundings.
The inhibition of Olfr486 involves a sophisticated interplay of chemical modulators, each meticulously targeting key components of intracellular signaling pathways associated with this GPCR. These inhibitors act through diverse mechanisms, finely tuned to disrupt specific cellular processes. Compounds targeting the MAPK pathway, such as Sorafenib and SB 203580, exert their influence downstream, modulating elements like SPRY4, thereby indirectly inhibiting Olfr486. Pertussis Toxin interferes with G protein subunits, impacting GPCR signaling and contributing to Olfr486 inhibition. Additionally, molecules like Thapsigargin and Thioridazine, influencing intracellular calcium dynamics, alter calmodulin-associated cascades, indirectly impacting Olfr486 activity. Inhibition through the PI3K-AKT pathway, facilitated by compounds like Wortmannin and LY294002, showcases the intricacies of signaling modulation, ultimately influencing Olfr486 function. The diversity in mechanisms highlights the complexity of GPCR inhibition, providing insights into potential avenues for further research in understanding olfactory transduction processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Multikinase inhibitor targeting RAF and VEGFR, indirectly impacting Olfr486 by disrupting downstream signaling cascades. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inhibits Gαi proteins, affecting GPCR signaling and leading to indirect inhibition of Olfr486. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Induces ER stress by inhibiting SERCA, triggering unfolded protein response (UPR) and influencing Olfr486 activity indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr486 inhibition indirectly. | ||||||
OG-L002 | 1357302-64-7 | sc-478221 | 5 mg | $270.00 | ||
Targets Rho kinase, modulating cytoskeletal dynamics and GPCR signaling, indirectly inhibiting Olfr486. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Alters intracellular calcium levels, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr486. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Selective p38 MAPK inhibitor impacting downstream effectors, contributing to Olfr486 inhibition through the MAPK pathway indirectly. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor, disrupting downstream signaling pathways and contributing to Olfr486 inhibition indirectly. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Calmodulin kinase II (CaMKII) inhibitor, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr486. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr486 inhibition indirectly. | ||||||